{"id":"W1532468082","doi":"10.1111/j.1600-6143.2012.04031.x","title":"Alternative Immunomodulatory Strategies for Xenotransplantation: CD40/154 Pathway-Sparing Regimens Promote Xenograft Survival","year":2012,"lang":"en","type":"article","venue":"American Journal of Transplantation","topic":"Xenotransplantation and immune response","field":"Medicine","cited_by":82,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Alberta","funders":"National Institute of Allergy and Infectious Diseases; Teva Pharmaceutical Industries; National Center for Research Resources; Amgen","keywords":"Medicine; Xenotransplantation; Basiliximab; Belatacept; Immunosuppression; Transplantation; Calcineurin; Abatacept; Tolerability; Immunology; Oncology; Tacrolimus; Internal medicine; Rituximab; Adverse effect; Kidney transplantation","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002793041,0.0003526016,0.0003821888,0.0003211214,0.0001822495,0.0005365454,0.0002309892,0.0002410183,0.001471033],"category_scores_gemma":[0.0001153996,0.00005931111,0.0002523347,0.0001621038,0.0002008992,0.0003137325,0.0002095582,0.0007733256,0.0002309938],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001823129,"about_ca_system_score_gemma":0.000224161,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001745914,"about_ca_topic_score_gemma":0.0005247729,"domain_scores_codex":[0.9998622,0.00002600323,0.00001370079,0.00002426377,0.00003090671,0.00004293509],"domain_scores_gemma":[0.9998997,0.00001448059,0.00002544188,0.00001953576,0.000006901201,0.00003388898],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.001938275,0.002248915,0.001761811,0.0001438719,0.00004519086,0.0002086505,0.0000777795,0.0006299199,0.9616925,0.0004691983,0.0003401619,0.03044387],"study_design_scores_gemma":[0.0006257337,0.02791826,0.02735634,0.00008317661,0.0002272416,0.002256532,0.0001180611,0.003068995,0.923572,0.0004512896,0.01429684,0.00002554619],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.993677,0.001767275,0.002784703,0.00007537955,0.00005477685,0.000100045,0.0001529262,0.00004759087,0.001340449],"genre_scores_gemma":[0.994383,0.001256319,0.003277726,0.00009823883,0.00003544181,0.00009532437,0.0002807027,0.00001213167,0.000561055],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001471033,"threshold_uncertainty_score":0.004921138,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02283548916321968,"score_gpt":0.298719682971774,"score_spread":0.2758841938085543,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}